DLC1 antibody [C2C3], C-term

GeneTex

DLC1 antibody [C2C3], C-term

9

WB: 1:500-1:3000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.

Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

1 mg/ml

Unconjugated

DLC1

DLC1 Rho GTPase activating protein

ARHGAP7, HP, STARD12, p122-RhoGAP, rho GTPase-activating protein 7, Rho-GTPase-activating protein 7, START domain-containing protein 12, StAR-related lipid transfer (START) domain containing 12, deleted in liver cancer 1 protein, epididymis secretory sperm binding protein, rho-type GTPase-activating protein 7

Rabbit

IgG

Rho GTPase-activating protein 7

This gene is deleted in the primary tumor of hepatocellular carcinoma. It maps to 8p22-p21.3, a region frequently deleted in solid tumors. It is suggested that this gene is a candidate tumor suppressor gene for human liver cancer, as well as for prostate, lung, colorectal, and breast cancers. Alternative splicing at this locus results in several transcript variants encoding different isoforms. [provided by RefSeq]

-20°C or -80°C,2°C to 8°C

12352203